Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women.
When lifestyle measures and antacids are inadequate, and when no alarm symptoms are present, pantoprazole has a better risk-benefit balance than H2 receptor agonists.
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000075202:Contraindications; D017277:Drug Approval; D005060:Europe; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D017442:Histamine Agonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D004366:Nonprescription Drugs / Q000627:therapeutic use; D000077402:Pantoprazole; D011247:Pregnancy; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000863:Antacids; D000897:Anti-Ulcer Agents; D017442:Histamine Agonists; D004366:Nonprescription Drugs; D054328:Proton Pump Inhibitors; D000077402:Pantoprazole